RS

Roger Sawhney

Chief Financial Officer

Roger Sawhney



Current Position



Chief Financial Officer (CFO)
  • Company: LB Pharmaceuticals, Inc.

  • Industry: Pharmaceuticals

  • Location: New York, NY, USA


Professional Experience and Background



  • Current Role:

  • Roger Sawhney serves as the Chief Financial Officer (CFO) at LB Pharmaceuticals, Inc., a company focused on neuro-psychological disorders. As CFO, his responsibilities likely encompass strategic financial planning, accounting, risk management, and financial reporting.

  • Significant emphasis on innovation within the biopharma sector, contributing both operational management and healthcare investment insights.


  • Recent Experience:

  • Garuda Therapeutics, Inc.: Chief Financial Officer (September 2022 to December 2023)

  • Omega Therapeutics, Inc.: CFO (March 2020 to May 2022) and Chief Business Officer (May 2022 to September 2022)

  • Novartis AG: Senior Vice President, Head of Global Corporate Strategy (July 2009 to August 2012)

  • Outcome Health: Senior Vice President of Corporate Strategy and Business Development (February 2017 to February 2018)

  • KKR & Co. Inc.: Director of Healthcare Investment Platform, Americas (September 2018 to August 2020)

  • Bain & Company: Partner (August 2012 to February 2017)

  • Boston Consulting Group: Partner (1996 to 2009)


Educational Background



  • Harvard Medical School

  • Degree: M.D. (Doctor of Medicine)


  • Stanford University

  • Degree: B.A. in Economics


Board Memberships



  • Adlai Nortye Ltd.:

  • Recently appointed to the Board of Directors (August 8, 2024)

  • Adlai Nortye is a global clinical-stage biotechnology company specializing in innovative cancer therapies, with operations in the U.S., China, and Singapore.


Specializations and Industry Focus



  • Healthcare Investments: Experienced in leveraging financial strategies for growth and development within healthcare and biopharma sectors.

  • Operational Management: Proven expertise in managing biopharma operations, ensuring both financial stability and innovation.

  • Corporate Strategy: Strong background in formulating and executing corporate strategies for major firms within the healthcare and biotech industries.

  • Innovation and Entrepreneurship: Focus on venture creation and driving new growth avenues in pharmaceuticals and therapeutics.


Notable Attributes



  • Strategic Leadership: Demonstrated ability to lead financial and business strategy for fast-growing, clinical-stage companies.

  • Global Perspective: Insightful experience from working with global giants in healthcare, consultancy, and investment sectors.

  • Financial Expertise: Deep understanding of financial nuances and strategic investments, particularly in biopharma and therapeutics.


Professional Affiliations





Key Contributions and Skills



  • Financial Acumen: Managed and directed financial strategies for leading biopharma companies, driving fiscal discipline and growth.

  • Strategic Investments: Led significant investment projects within major healthcare platforms, emphasizing growth and equity.

  • Leadership in Biotechnology: Guided biopharma firms through various stages of growth and development, enhancing their market presence and operational capacity.


Roger Sawhney's professional trajectory and roles underline his robust capacity to drive financial and strategic growth within high-paced, innovative biopharma contexts. His expertise presents valuable synergies for academic engagements, advanced research collaborations, and corporate financial optimization.